[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ITMI20031127A1 - Anticorpi anti-hgf-r e loro uso - Google Patents

Anticorpi anti-hgf-r e loro uso

Info

Publication number
ITMI20031127A1
ITMI20031127A1 IT001127A ITMI20031127A ITMI20031127A1 IT MI20031127 A1 ITMI20031127 A1 IT MI20031127A1 IT 001127 A IT001127 A IT 001127A IT MI20031127 A ITMI20031127 A IT MI20031127A IT MI20031127 A1 ITMI20031127 A1 IT MI20031127A1
Authority
IT
Italy
Prior art keywords
antibodies
hgf
relates
hfg
secretes
Prior art date
Application number
IT001127A
Other languages
English (en)
Inventor
Maria Giovanna Prat
Original Assignee
Uni Degli Studi Del Piemont E Orientale Am
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Degli Studi Del Piemont E Orientale Am filed Critical Uni Degli Studi Del Piemont E Orientale Am
Priority to IT001127A priority Critical patent/ITMI20031127A1/it
Publication of ITMI20031127A0 publication Critical patent/ITMI20031127A0/it
Priority to AT04741691T priority patent/ATE466031T1/de
Priority to DK04741691.2T priority patent/DK1641828T3/da
Priority to US10/559,305 priority patent/US7556804B2/en
Priority to CA002524329A priority patent/CA2524329A1/en
Priority to EP04741691A priority patent/EP1641828B1/en
Priority to DE602004026872T priority patent/DE602004026872D1/de
Priority to PCT/EP2004/050976 priority patent/WO2004108766A2/en
Publication of ITMI20031127A1 publication Critical patent/ITMI20031127A1/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75Agonist effect on antigen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/81Packaged device or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IT001127A 2003-06-05 2003-06-05 Anticorpi anti-hgf-r e loro uso ITMI20031127A1 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT001127A ITMI20031127A1 (it) 2003-06-05 2003-06-05 Anticorpi anti-hgf-r e loro uso
AT04741691T ATE466031T1 (de) 2003-06-05 2004-06-01 Anti-hgf-r-antikörper und deren verwendung
DK04741691.2T DK1641828T3 (da) 2003-06-05 2004-06-01 Anti-HGF-R-antistoffer og deres anvendelse
US10/559,305 US7556804B2 (en) 2003-06-05 2004-06-01 Anti-HGF-R antibodies and their use
CA002524329A CA2524329A1 (en) 2003-06-05 2004-06-01 Anti-hgf-r antibodies and their use
EP04741691A EP1641828B1 (en) 2003-06-05 2004-06-01 Anti-hgf-r antibodies and their use
DE602004026872T DE602004026872D1 (de) 2003-06-05 2004-06-01 Anti-hgf-r-antikörper und deren verwendung
PCT/EP2004/050976 WO2004108766A2 (en) 2003-06-05 2004-06-01 Anti-hgf-r antibodies and their use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001127A ITMI20031127A1 (it) 2003-06-05 2003-06-05 Anticorpi anti-hgf-r e loro uso

Publications (2)

Publication Number Publication Date
ITMI20031127A0 ITMI20031127A0 (it) 2003-06-05
ITMI20031127A1 true ITMI20031127A1 (it) 2004-12-06

Family

ID=30131145

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001127A ITMI20031127A1 (it) 2003-06-05 2003-06-05 Anticorpi anti-hgf-r e loro uso

Country Status (8)

Country Link
US (1) US7556804B2 (it)
EP (1) EP1641828B1 (it)
AT (1) ATE466031T1 (it)
CA (1) CA2524329A1 (it)
DE (1) DE602004026872D1 (it)
DK (1) DK1641828T3 (it)
IT (1) ITMI20031127A1 (it)
WO (1) WO2004108766A2 (it)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PA8849001A1 (es) * 2008-11-21 2010-06-28 Lilly Co Eli Anticuerpos de c-met
MX2011010166A (es) 2009-04-07 2011-10-11 Roche Glycart Ag Anticuerpos biespecificos anti-erbb-3/anti-c-met.
SG175078A1 (en) 2009-04-07 2011-11-28 Roche Glycart Ag Bispecific anti-erbb-1/anti-c-met antibodies
KR101671378B1 (ko) * 2009-10-30 2016-11-01 삼성전자 주식회사 c-Met에 특이적으로 결합하는 항체 및 그의 용도
KR101748707B1 (ko) * 2009-11-27 2017-06-20 삼성전자주식회사 c-Met에 특이적으로 결합하는 항체 및 그를 이용한 암 진단용 키트
ITTO20091020A1 (it) * 2009-12-21 2011-06-22 Uni Degli Studi Del Piemonte Orientale Ame "cardiomyocytes anti-apoptotic molecules, products and compositions thereof"
NZ602294A (en) 2010-03-10 2015-04-24 Genmab As Monoclonal antibodies against c-met
RU2608644C2 (ru) 2010-11-03 2017-01-23 арДЖЕН-ИКС Н.В. Антитела против белка рецептора с-мет
MX2014002289A (es) 2011-08-26 2015-03-20 Merrimack Pharmaceuticals Inc Anticuerpos fc especificos en tandem.
CA2843771A1 (en) 2011-09-20 2013-03-28 Eli Lilly And Company Anti-c-met antibodies
EP2773660A2 (en) 2011-11-03 2014-09-10 Argen-X B.V. Chimeric human-camel antigens and their use
US8900582B2 (en) 2011-12-22 2014-12-02 Samsung Electronics Co., Ltd. Deimmunized anti c-Met humanized antibodies and uses thereof
EP2727941A1 (en) 2012-11-05 2014-05-07 MAB Discovery GmbH Method for the production of multispecific antibodies
WO2014067642A1 (en) 2012-11-05 2014-05-08 Mab Discovery Gmbh Method for the production of multispecific antibodies
WO2014138449A1 (en) 2013-03-06 2014-09-12 Merrimack Pharmaceuticals, Inc. Anti-c-met tandem fc bispecific antibodies
US9168300B2 (en) 2013-03-14 2015-10-27 Oncomed Pharmaceuticals, Inc. MET-binding agents and uses thereof
KR20160137599A (ko) 2014-03-24 2016-11-30 제넨테크, 인크. C-met 길항제로의 암 치료 및 이것과 hgf 발현과의 상관관계
WO2016042412A1 (en) 2014-09-16 2016-03-24 Symphogen A/S Anti-met antibodies and compositions
WO2016149265A1 (en) 2015-03-16 2016-09-22 Kolltan Pharmaceuticals, Inc. Anti-met antibodies and methods of use thereof
GB201611123D0 (en) 2016-06-27 2016-08-10 Euremab Srl Anti met antibodiesand uses thereof
TWI782930B (zh) 2016-11-16 2022-11-11 美商再生元醫藥公司 抗met抗體,結合met之雙特異性抗原結合分子及其使用方法
IT201800000535A1 (it) 2018-01-03 2019-07-03 Procedimenti per la cura del cancro.
KR102396194B1 (ko) * 2018-12-07 2022-05-10 서울대학교 산학협력단 항 c-Met 아고니스트 항체 및 이의 용도
KR102433184B1 (ko) * 2018-12-07 2022-08-17 서울대학교 산학협력단 항 c-Met 아고니스트 항체 및 이의 용도
JP2022547274A (ja) 2019-09-16 2022-11-11 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 免疫pet撮像のための放射標識されたmet結合タンパク質

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT67009A (en) 1991-05-10 1995-01-30 Erba Carlo Spa Truncated forms of the hepatocyte growth factor (hgf) receptor pharmaceutical compositions containing them and process for production of them
US5686292A (en) * 1995-06-02 1997-11-11 Genentech, Inc. Hepatocyte growth factor receptor antagonist antibodies and uses thereof
US6214344B1 (en) * 1995-06-02 2001-04-10 Genetech, Inc. Hepatocyte growth factor receptor antagonists and uses thereof
DK0922102T3 (da) * 1996-07-03 2010-08-16 Genentech Inc Receptor-agonister af hepatocyt-vækstfaktor og anvendelser deraf

Also Published As

Publication number Publication date
US7556804B2 (en) 2009-07-07
WO2004108766A2 (en) 2004-12-16
US20060140940A1 (en) 2006-06-29
DE602004026872D1 (de) 2010-06-10
EP1641828B1 (en) 2010-04-28
DK1641828T3 (da) 2010-08-02
WO2004108766A3 (en) 2005-06-30
ATE466031T1 (de) 2010-05-15
EP1641828A2 (en) 2006-04-05
ITMI20031127A0 (it) 2003-06-05
CA2524329A1 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
ITMI20031127A1 (it) Anticorpi anti-hgf-r e loro uso
RS53984B1 (en) IP-10 ANTIBODIES AND THEIR USES
CY1112277T1 (el) ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΟΙ ΑΝΤΑΓΩΝΙΣΤΕΣ ΑΝΤΙ-β7 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ
NO20071436L (no) Humaniserte Anti-5T4 antistoffer og Anti-5T4 antistoff/calicheamicin konjugater
DK1773885T3 (da) Humaniserede anti-c-met-antagonister
CY2012019I1 (el) Ανθρωπινα μονοκλωνα αντισωματα εναντια στο cd20
EA200401198A1 (ru) АНТИТЕЛА ПРОТИВ αvβ6
EA200700083A1 (ru) Антитела, направленные против бета-амилоидного пептида, и способы их применения
AR057807A1 (es) Formulaciones de anticuerpo anti-cd3
NZ594466A (en) Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies
CY1110759T1 (el) Παραλλαγες ανοσοσφαιρινων και χρησεις αυτων
ATE502052T1 (de) Monoklonale antikörper gegen den humanen anti- müllerian-hormonrezeptor vom typ ii (amhr-ii)
AR052284A1 (es) Variantes de un anticuerpo y usos de las mismas
ATE553778T1 (de) Für humanes hepcidin spezifische antikörper
CL2007003825A1 (es) Composicion farmaceutica que comprende un anticuerpo monoclonal humanizado anti-antigeno de diferenciacion leucocitario humano cd6; y su uso para el diagnostico y tratamiento de la leucemia linfocitaria cronica b.
UA94211C2 (ru) Выделенное полностью человеческое моноклональное cd3 антитело
FI20020807A0 (fi) Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita
ATE506966T1 (de) Humanisierte super-antikörper